Literature DB >> 8163642

The urokinase receptor is required for human monocyte chemotaxis in vitro.

M R Gyetko1, R F Todd, C C Wilkinson, R G Sitrin.   

Abstract

Mononuclear phagocytes (Mphi) produce urokinase-type plasminogen activator (uPA) and also express a specific cell-surface receptor for urokinase, uPAR. The concomitant expression of these proteins provides a mechanism by which Mphi can degrade extracellular matrix proteins during directed cell migration. In this study, we sought to determine if uPAR plays a role in Mphi chemotaxis that is distinct from its role in matrix proteolysis. Exposing adherent monocytes to a chemotactic gradient causes plasma membrane uPAR to localize strongly to the leading edge of cell migration. Adherence alone or exposure to FMLP had no effect on uPAR expression. Using Boyden chamber chemotaxis assays, we demonstrate that treating mononuclear cells with an anti-uPAR mAb (either as an intact mAb or F[ab']2) ablates chemotaxis induced by FMLP and monocyte chemotactic peptide-1 (P < 0.001). Inactivating the catalytic activity of uPAR-bound uPA had no effect on chemotaxis. Similarly, blocking uPAR expression with an antisense oligonucleotide to uPAR completely ablates chemotaxis, but blocking uPA expression with an antisense oligonucleotide to uPA has a minimal effect. We therefore demonstrate that expression and unimpeded function of uPAR plays an obligate role in M phi chemotaxis by mechanisms that are largely independent of its ligand, uPA. Combined with its known role in mediating pericellular proteolysis, these observations demonstrate that uPAR is essential for both locomotion and traversing tissue barriers during M phi migration.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8163642      PMCID: PMC294150          DOI: 10.1172/JCI117114

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  54 in total

1.  Two functional domains in the phagocyte membrane glycoprotein Mo1 identified with monoclonal antibodies.

Authors:  N Dana; B Styrt; J D Griffin; R F Todd; M S Klempner; M A Arnaout
Journal:  J Immunol       Date:  1986-11-15       Impact factor: 5.422

2.  Proliferation of a human epidermal tumor cell line stimulated by urokinase.

Authors:  J C Kirchheimer; J Wojta; G Christ; B R Binder
Journal:  FASEB J       Date:  1987-08       Impact factor: 5.191

Review 3.  Vascular cell interactions with special reference to the pathogenesis of atherosclerosis.

Authors:  P F Davies
Journal:  Lab Invest       Date:  1986-07       Impact factor: 5.662

4.  Urokinase-type plasminogen activator and its inhibitor secreted by cultured human monocyte-macrophages.

Authors:  O Saksela; T Hovi; A Vaheri
Journal:  J Cell Physiol       Date:  1985-01       Impact factor: 6.384

Review 5.  Membrane receptors for extracellular matrix macromolecules: relationship to cell adhesion and tumor metastasis.

Authors:  R L Juliano
Journal:  Biochim Biophys Acta       Date:  1987-11-25

Review 6.  Plasminogen activators, tissue degradation, and cancer.

Authors:  K Danø; P A Andreasen; J Grøndahl-Hansen; P Kristensen; L S Nielsen; L Skriver
Journal:  Adv Cancer Res       Date:  1985       Impact factor: 6.242

7.  Urokinase: a chemotactic factor for polymorphonuclear leukocytes in vivo.

Authors:  M D Boyle; V A Chiodo; M J Lawman; A P Gee; M Young
Journal:  J Immunol       Date:  1987-07-01       Impact factor: 5.422

8.  The human urokinase-plasminogen activator gene and its promoter.

Authors:  A Riccio; G Grimaldi; P Verde; G Sebastio; S Boast; F Blasi
Journal:  Nucleic Acids Res       Date:  1985-04-25       Impact factor: 16.971

9.  A monoclonal antibody specific for a monocyte-macrophage membrane component blocks the human monocyte response to migration inhibitory factor.

Authors:  D Y Liu; R F Todd
Journal:  J Immunol       Date:  1986-07-15       Impact factor: 5.422

10.  Plasmin degradation of cartilage proteoglycan.

Authors:  E Mochan; T Keler
Journal:  Biochim Biophys Acta       Date:  1984-08-21
View more
  70 in total

Review 1.  The plasmin cascade and matrix metalloproteinases in non-small cell lung cancer.

Authors:  G Cox; W P Steward; K J O'Byrne
Journal:  Thorax       Date:  1999-02       Impact factor: 9.139

2.  The antiangiogenic agent Neovastat (AE-941) stimulates tissue plasminogen activator activity.

Authors:  Denis Gingras; Dominique Labelle; Carine Nyalendo; Dominique Boivin; Michel Demeule; Chantal Barthomeuf; Richard Béliveau
Journal:  Invest New Drugs       Date:  2004-01       Impact factor: 3.850

3.  Formation of polyomavirus-like particles with different VP1 molecules that bind the urokinase plasminogen activator receptor.

Authors:  Young C Shin; William R Folk
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

4.  Antagonistic anti-urokinase plasminogen activator receptor (uPAR) antibodies significantly inhibit uPAR-mediated cellular signaling and migration.

Authors:  Sai Duriseti; David H Goetz; Daniel R Hostetter; Aaron M LeBeau; Ying Wei; Charles S Craik
Journal:  J Biol Chem       Date:  2010-05-25       Impact factor: 5.157

5.  Concurrent upregulation of urokinase plasminogen activator receptor and CD11b during tuberculosis and experimental endotoxemia.

Authors:  N P Juffermans; P E Dekkers; A Verbon; P Speelman; S J van Deventer; T van der Poll
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

6.  Urokinase receptor cleavage: a crucial step in fibroblast-to-myofibroblast differentiation.

Authors:  Audrey M Bernstein; Sally S Twining; Debra J Warejcka; Edward Tall; Sandra K Masur
Journal:  Mol Biol Cell       Date:  2007-05-16       Impact factor: 4.138

7.  Reaction patterns of pulmonary macrophages in protracted asphyxiation.

Authors:  Theresa Strunk; Dorothee Hamacher; Ronald Schulz; Bernd Brinkmann
Journal:  Int J Legal Med       Date:  2010-02-12       Impact factor: 2.686

8.  Factor Xa as an interface between coagulation and inflammation. Molecular mimicry of factor Xa association with effector cell protease receptor-1 induces acute inflammation in vivo.

Authors:  G Cirino; C Cicala; M Bucci; L Sorrentino; G Ambrosini; G DeDominicis; D C Altieri
Journal:  J Clin Invest       Date:  1997-05-15       Impact factor: 14.808

9.  4G/5G plasminogen activator inhibitor-1 polymorphisms and haplotypes are associated with pneumonia.

Authors:  Sachin Yende; Derek C Angus; Jingzhong Ding; Anne B Newman; John A Kellum; Rongling Li; Robert E Ferrell; Joseph Zmuda; Stephen B Kritchevsky; Tamara B Harris; Melissa Garcia; Kristine Yaffe; Richard G Wunderink
Journal:  Am J Respir Crit Care Med       Date:  2007-08-29       Impact factor: 21.405

10.  Increased interleukin-1alpha and interleukin-1beta production by macrophages of low-density lipoprotein receptor knock-out mice stimulated with lipopolysaccharide is CD11c/CD18-receptor mediated.

Authors:  M G Netea; P N Demacker; B J Kullberg; O C Boerman; I Verschueren; A F Stalenhoef; J W Van Der Meer
Journal:  Immunology       Date:  1998-11       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.